The FDA approved Vertex Pharmaceuticals’ Journavx, a new non-opioid pain pill for short-term pain. While safer than opioids, ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

Discover the health benefits of tea, its cultural significance in India, and the FDA’s recognition of tea as a healthy ...

Qartemi is a 'living drug' that has been approved by the Central Drugs Standard Control Organisation (CDSCO) for blood cancer ...

Cotecna Life Sciences India Private Limited, formerly Geo-Chem Pharma, is proud to announce the inauguration of its new, ...

US Federal officials have approved a new pain pill by Vertex Pharmaceuticals called Journavx, aimed at reducing addiction and ...

Lisdexamfetamine Dimesylate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in adults and ...

Shimla police uncovered an organized drug supply chain involving 500 individuals, led by kingpin Sandeep Shah.

India's MedPlus Health Services reported a surge in third-quarter profit on Friday, driven by store expansions and strong demand for over-the-counter medicines.

Budget 2025 hopes to extend financial incentives to clinical research industry for developing cutting-edge therapies in India ...

Breakthrough in diabetes treatment! The US FDA approves Ozempic for reducing kidney disease risk in diabetic patients. Learn ...